BriaCell Therapeutics Corp. Warrant
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch BCTXW and buy or sell other stocks, ETFs, and their options commission-free!About BCTXW
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer.
CEOWilliam V. Williams, MD
CEOWilliam V. Williams, MD
Employees—
Employees—
HeadquartersWest Vancouver, British Columbia
HeadquartersWest Vancouver, British Columbia
Founded2006
Founded2006
Employees—
Employees—
BCTXW Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume19.52K
Average volume19.52K
High today$0.0441
High today$0.0441
Low today$0.0377
Low today$0.0377
Open price$0.04
Open price$0.04
Volume13.00K
Volume13.00K
52 Week high$0.4798
52 Week high$0.4798
52 Week low$0.0113
52 Week low$0.0113
Stock Snapshot
BriaCell Therapeutics Corp. Warrant(BCTXW) stock is priced at $0.04.
On 2025-12-13, BriaCell Therapeutics Corp. Warrant(BCTXW) stock moved within a range of $0.04 to $0.04. With shares now at $0.04, the stock is trading 0.0% above its intraday low and -14.5% below the session's peak.
Trading volume for BriaCell Therapeutics Corp. Warrant(BCTXW) stock has reached 13K, versus its average volume of 19.52K.
The stock's 52-week range extends from a low of $0.01 to a high of $0.48.
The stock's 52-week range extends from a low of $0.01 to a high of $0.48.